First human tests for kidney disease drug begin
NCT ID NCT07426380
Summary
This early-stage study aims to understand how a new drug called eloralintide behaves in people with severe kidney problems compared to healthy people. Researchers will give a single injection to 28 participants and track how much drug gets into their blood and how long it stays. The main goal is to gather safety information and see if kidney function affects how the body processes the drug.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL IMPAIRMENT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Floridian Clinical Research, LLC
RECRUITINGMiami Lakes, Florida, 33016-1518, United States
Contact Phone: •••-•••-••••
Contact
-
Omega Research Orlando LLC
RECRUITINGOrlando, Florida, 32808, United States
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.